TransMedics Group, Inc.
TMDX
$93.50
-$0.68-0.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 70.11% | 116.58% | 1,318.18% | 562.71% | 159.99% |
| Total Depreciation and Amortization | 57.56% | 173.48% | 230.39% | 234.27% | 180.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.09% | -72.94% | 54.45% | 100.00% | 128.26% |
| Change in Net Operating Assets | -4.91% | 27.60% | 101.49% | -146.61% | -318.60% |
| Cash from Operations | 136.79% | 199.84% | 543.18% | 60.34% | 305.80% |
| Capital Expenditure | 67.46% | 55.25% | -1,621.96% | -4,665.05% | -1,412.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 102.96% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.46% | 68.12% | -1,621.96% | -4,665.05% | -1,412.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.35% | 416.22% | 1,409.36% | -19.53% | -69.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.35% | 416.22% | -97.30% | -19.53% | -69.85% |
| Foreign Exchange rate Adjustments | -335.27% | 318.08% | -1,340.00% | -336.99% | -35.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.30% | 78.98% | -96.76% | -702.50% | -884.70% |